Martin-Castillo, B., Lopez-Bonet, E., Cuyàs, E., Viñas, G., Pernas, S., Dorca, J., & Menendez, J. A. (2015). Cancer stem cell-driven efficacy of trastuzumab (Herceptin): Towards a reclassification of clinically HER2-positive breast carcinomas. Oncotarget.

Martin-Castillo, Begoña, Eugeni Lopez-Bonet, Elisabet Cuyàs, Gemma Viñas, Sonia Pernas, Joan Dorca, and Javier A. Menendez. "Cancer Stem Cell-driven Efficacy of Trastuzumab (Herceptin): Towards a Reclassification of Clinically HER2-positive Breast Carcinomas." Oncotarget 2015.

Martin-Castillo, Begoña, et al. "Cancer Stem Cell-driven Efficacy of Trastuzumab (Herceptin): Towards a Reclassification of Clinically HER2-positive Breast Carcinomas." Oncotarget 2015.